- PR Newswire•1 hour agoTEVA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds INSTITUTIONAL Investors with Losses in Excess of $500,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA
NEW ORLEANS, Dec. 2, 2016 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until ...
- Market Realist•12 hours ago
Currently, investors are concerned about Valeant’s (VRX) massive $30-billion-plus debt. Therefore, Valeant’s primary focus is on debt reduction.
TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||36.52 x 1500|
|Ask||36.53 x 1500|
|Day's Range||36.41 - 37.11|
|52 Week Range||36.41 - 66.55|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||21.25|
|Dividend & Yield||1.36 (3.61%)|
|1y Target Est||N/A|